This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

U.K. surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted ...

Briton with cancer operated on by doctor located 1,500 miles away using four-armed robot fitted with 3D camera The patient was in Gibraltar. The surgeon was in London. The outcome was a remarkable ...

JACKSONVILLE, Fla. – Prostate cancer is the most common cancer in men in the U.S. after skin cancer, but it is often slow-growing and highly treatable. Now there is a minimally invasive treatment, ...

The depictions in this story may be graphic to some readers. LOUISVILLE, Ky. (WDRB) — A southern Indiana doctor was fired by Norton Healthcare and had his state license suspended after several ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

Patriots defensive coordinator Terrell Williams is in Santa Clara, soaking in Super Bowl week, after winning his biggest battle as prostate cancer experts say his perseverance will help save lives.

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between scans or start aggressive treatment. Those with certain types of medium-risk ...

What if a simple conversation could save your life? For thousands of men each year, talking openly about prostate cancer and taking action makes all the difference. Prostate cancer is the most common ...

DEAR DR. ROACH: I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...